| commit | d96072a845301ea42ed500907c04aadbf1a8f342 | [log] [tgz] |
|---|---|---|
| author | Googler <ahumesky@google.com> | Wed Feb 08 13:00:18 2023 -0800 |
| committer | Copybara-Service <copybara-worker@google.com> | Wed Feb 08 13:01:43 2023 -0800 |
| tree | eec728f0124b88ab5f9d45f74940da80bb5a6bb1 | |
| parent | bb7d83cce71c790404d7a83039069a9b07258682 [diff] |
Update android tools to 0.28.0 to update the Android manifest merger to v30.1.3. This also effectively drops support for legacy (pre-D8) desugaring, because the legacy desugaring code is no longer included in the Bazel Android tools. RELNOTES: Update Android manifest merger to v30.1.3, and also drop support for legacy (pre-D8) desugaring. PiperOrigin-RevId: 508160419 Change-Id: I6f975584d9dee18828b412c53d52b693c5936040
{Fast, Correct} - Choose two
Build and test software of any size, quickly and reliably.
Speed up your builds and tests: Bazel rebuilds only what is necessary. With advanced local and distributed caching, optimized dependency analysis and parallel execution, you get fast and incremental builds.
One tool, multiple languages: Build and test Java, C++, Android, iOS, Go, and a wide variety of other language platforms. Bazel runs on Windows, macOS, and Linux.
Scalable: Bazel helps you scale your organization, codebase, and continuous integration solution. It handles codebases of any size, in multiple repositories or a huge monorepo.
Extensible to your needs: Easily add support for new languages and platforms with Bazel's familiar extension language. Share and re-use language rules written by the growing Bazel community.
Follow our tutorials:
To report a security issue, please email security@bazel.build with a description of the issue, the steps you took to create the issue, affected versions, and, if known, mitigations for the issue. Our vulnerability management team will respond within 3 working days of your email. If the issue is confirmed as a vulnerability, we will open a Security Advisory. This project follows a 90 day disclosure timeline.
See CONTRIBUTING.md
